John Orloff
2019
In 2019, John Orloff earned a total compensation of $5.6M as Executive Vice President, Head of Research and Development at Alexion Pharmaceuticals, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $960,498 |
|---|---|
| Salary | $770,000 |
| Stock Awards | $3,863,694 |
| Other | $32,550 |
| Total | $5,626,742 |
Orloff received $3.9M in stock awards, accounting for 69% of the total pay in 2019.
Orloff also received $960.5K in non-equity incentive plan, $770K in salary and $32.6K in other compensation.
Rankings
In 2019, John Orloff's compensation ranked 1,869th out of 13,971 executives tracked by ExecPay. In other words, Orloff earned more than 86.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,869 out of 13,971 | 87th |
Division Manufacturing | 669 out of 5,695 | 88th |
Major group Chemicals And Allied Products | 205 out of 2,194 | 91st |
Industry group Drugs | 163 out of 1,880 | 91st |
Industry Pharmaceutical Preparations | 121 out of 1,392 | 91st |
Source: SEC filing on March 26, 2020.
Orloff's colleagues
We found five more compensation records of executives who worked with John Orloff at Alexion Pharmaceuticals in 2019.
2019
Ludwig Hantson
Alexion Pharmaceuticals
Chief Executive Officer
2019
Paul Clancy
Alexion Pharmaceuticals
Chief Financial Officer
2019
Brian Goff
Alexion Pharmaceuticals
Executive Vice President, Chief Commercial and Global Operations Officer
2019
Anne-Marie Law
Alexion Pharmaceuticals
Executive Vice President, Chief Human Experience Officer
2019
Aradhana Sarin
Alexion Pharmaceuticals